Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-12

Clinical Trial Update: Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update on pilocarpine ophthalmic topical cream for dry eye disease and keratoconjunctivitis sicca reports safety and efficacy findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pilocarpine ophthalmic topical cream (pilocarpine)

Snippet

Sponsor: Glaukos Corporation | Conditions: Dry Eye Disease, Kerato Conjunctivitis Sicca | Phase 2 | Status: COMPLETED